Harbour BioMed Predicts Significant Profit Growth for First Half of 2025 Harbour BioMed has issued an optimistic profit forecast for the first half of 2025, projecting earnings between $68 million and $74 million, driven by strategic partnerships and innovative collaborations.

Harbour BioMed Predicts Significant Profit Growth for First Half of 2025 #None #AstraZeneca #Harbour_BioMed #HBICE